Target intelligence / Profile preview

Inactivated poliovirus type 1 (IPV type 1)

Target: IPV type 1
Molecular classification: Viral protein, Whole inactivated virus (antigen), Vaccine antigen, Other: Not a cell-derived therapeutic target, but a viral structural antigen

Overview

Inactivated poliovirus type 1 (IPV type 1) is a purified preparation of poliovirus serotype 1 (Mahoney strain), grown in cell culture and chemically inactivated with formaldehyde. It is used as a key antigenic component in inactivated polio vaccines, which are designed to induce protective immunity against poliovirus type 1, the main cause of paralytic poliomyelitis worldwide. The inactivated viral particles are noninfectious but stimulate the immune system to produce neutralizing antibodies, preventing both symptomatic and asymptomatic poliovirus infections. IPV type 1 is an essential public health tool for polio eradication and is delivered alone or in combination with other vaccines.

Other names: Poliovirus type 1 antigen (formaldehyde inactivated)Poliovirus type 1 (Mahoney strain, inactivated)Poliovirus immunogen, type 1IPV type 1 antigenSalk polio vaccine, type 1 componentTrivalent inactivated poliovirus vaccine (IPV, contains type 1 component)

Mechanism of action

Vaccine exposure to the inactivated poliovirus type 1 antigen induces the immune system to produce neutralizing antibodies against type 1 poliovirus, conferring protective immunity when exposed to the wild-type virus. The immune response is primarily humoral (antibody-mediated), blocking viral entry and viremia.

Biological functions

Induction of immune response (production of neutralizing antibodies)Prevention of poliovirus type 1 infectionGeneration of serotype-specific immunity

Disease associations

Infection (component of vaccines to prevent poliomyelitis caused by poliovirus, mainly type 1)Not implicated in cancer, cardiovascular disease, neurodegeneration, or chronic inflammation (used in infectious disease prevention)

Safety considerations

Vaccine safety profile is excellent, with rare allergic reactions to trace antibiotics (neomycin, streptomycin, polymyxin B) possible.Historical concern: Early batches (1955–1963) of inactivated vaccine were contaminated with simian virus 40 (SV40) before improved purification and monitoring, but modern preparations are not contaminated and are considered safe.Not suitable for use in people with known severe allergy to vaccine components.Usual vaccine safety risks (injection-site reactions, rare hypersensitivity, very rare anaphylaxis)

Interacting drugs

None in the sense of direct molecular interaction; it is a component of vaccines. However, vaccine formulations may include antibiotics such as neomycin, streptomycin, and polymyxin B as trace contaminants after purification.

1 more in the full profile.

Biomarkers

Serum anti-poliovirus type 1 neutralizing antibody titers (measured by D-antigen ELISA or microneutralization assays) are used for efficacy monitoring and immunization status

Beyond the preview

Go deeper on Inactivated poliovirus type 1 (IPV type 1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inactivated poliovirus type 1 (IPV type 1).

Explore the full profile